pLenti Lifeact-iRFP670 BlastR Citations (3)

Originally described in: The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion.
Padilla-Rodriguez M, Parker SS, Adams DG, Westerling T, Puleo JI, Watson AW, Hill SM, Noon M, Gaudin R, Aaron J, Tong D, Roe DJ, Knudsen B, Mouneimne G Nat Commun. 2018 Jul 30;9(1):2980. doi: 10.1038/s41467-018-05367-2. PubMed Journal

---

Articles Citing pLenti Lifeact-iRFP670 BlastR

Articles
Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioning. Watson AW, Grant AD, Parker SS, Hill S, Whalen MB, Chakrabarti J, Harman MW, Roman MR, Forte BL, Gowan CC, Castro-Portuguez R, Stolze LK, Franck C, Cusanovich DA, Zavros Y, Padi M, Romanoski CE, Mouneimne G. Cell Rep. 2021 Jun 29;35(13):109293. doi: 10.1016/j.celrep.2021.109293. PubMed
EVL and MIM/MTSS1 regulate actin cytoskeletal remodeling to promote dendritic filopodia in neurons. Parker SS, Ly KT, Grant AD, Sweetland J, Wang AM, Parker JD, Roman MR, Saboda K, Roe DJ, Padi M, Wolgemuth CW, Langlais P, Mouneimne G. J Cell Biol. 2023 May 1;222(5):e202106081. doi: 10.1083/jcb.202106081. Epub 2023 Feb 24. PubMed
Ena/VASP-EVH1 inhibition prevents chemotaxis and metastasis by blocking the EVH1-WAVE2 interaction. Muller M, Barone M, Dinther MV, Motzny K, Ren J, Eichhorst J, Albat D, Chiha S, Lehmann M, Volkmer R, Oschkinat H, Schmalz HG, Ten Dijke P, Kuhne R. Proc Natl Acad Sci U S A. 2025 Jul;122(26):e2423512122. doi: 10.1073/pnas.2423512122. Epub 2025 Jun 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.